Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z




Home | Contact Us
 Health and Human Services Logo



Animated FirstGov Logo - Click to enter FirstGov


Varicella (Chickenpox)

Contents
Home - National Notifiable Diseases Surveillance System
Overview
Introduction
List of Infectious Nationally Notifiable Condtions
List of Non-Infectious Nationally Notifiable Conditions
Alphabetical List of Case Definitions
Definition of Terms
Related Links
References
  Site Search


2010 Case Definition

CSTE Position Statement Number : 09-ID-68

Clinical description

An illness with acute onset of diffuse (generalized) maculo-papulovesicular rash without other apparent cause.

Laboratory criteria for diagnosis

  • Isolation of varicella virus from a clinical specimen, or
  • Varicella antigen detected by direct fluorescent antibody test, or
  • Varicella-specific nucleic acid detected by polymerase chain reaction (PCR), or
  • Significant rise in serum anti-varicella immunoglobulin G (IgG) antibody level by any standard serologic assay.

Case classification

Probable:
  • An acute illness with
    • Diffuse (generalized) maculopapulovesicular rash, AND
    • Lack of laboratory confirmation, AND
    • Lack of epidemiologic linkage to another probable or confirmed case.
Confirmed:
  • An acute illness with diffuse (generalized) maculopapulovesicular rash, AND
    • Epidemiologic linkage to another probable or confirmed case, OR
    • Laboratory confirmation by any of the following:
      • Isolation of varicella virus from a clinical specimen, OR
      • Varicella antigen detected by direct fluorescent antibody test, OR
      • Varicella-specific nucleic acid detected by polymerase chain reaction (PCR), OR
      • Significant rise in serum anti-varicella immunoglobulin G (IgG) antibody level by any standard serologic assay.

Comment

Two probable cases that are epidemiologically linked would be considered confirmed, even in the absence of laboratory confirmation.

In vaccinated persons who develop varicella more than 42 days after vaccination (breakthrough disease), the disease is almost always mild with fewer than 50 skin lesions and shorter duration of illness. The rash may also be atypical in appearance (maculopapular with few or no vesicles).

Laboratory confirmation of cases of varicella is not routinely recommended; laboratory confirmation is recommended for fatal cases and in other special circumstances.

See also:

Printable Version

 


 



Privacy Policy | Accessibility

Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated November 17, 2011

United States Department of Health and Human Services
Centers for Disease Control and Prevention